Immunocytochemical and histochemical analyses can help classify chronic SMA and understand pathogenic processes related to muscle maturational stage at disease onset.
Answers are grounded in this paper and cite their sources.
Muscle fiber analyses may refine chronic SMA subtyping; leaves open maturational-stage links and requires prospective validation.
Immunocytochemical and biochemical analyses were carried out on patients affected by chronic SMA. Three groups of patients were identified. In group I, the muscle presented a fascicular atrophy; a high percentage of atrophic type II fibers; and fibers expressing fast, slow, embryonic, and fetal myosin isoforms. In group II, the muscle was characterized by atrophic fibers and normal/hypertrophic fibers expressing only slow myosin isoforms. In group III, the muscle was characterized by fiber type grouping and fibers coexpressing fast and slow myosin isoforms but never embryonic or fetal MHC isoforms. The muscles of groups I and III contained both fast and slow myosins whereas group II muscles were predominantly slow by immunocytochemical analysis or only slow by biochemical analysis. In view of these results, immunocytochemical and histochemical analyses could help to classify chronic SMA and help to understand the different pathogenic processes which seem to be related to the maturational stage of the muscle at the age of onset of the disease.
No takes yet. Share an insight, caveat, or question.
Hamida et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: